Zlatan Mujagic
Zlatan Mujagic
M.D., Ph.D., Division of Gastroenterology and Hepatology, Maastricht University Medical Center
Verified email at maastrichtuniversity.nl
Title
Cited by
Cited by
Year
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
A Zhernakova, A Kurilshikov, MJ Bonder, EF Tigchelaar, M Schirmer, ...
Science 352 (6285), 565-569, 2016
7502016
Proton pump inhibitors affect the gut microbiome
F Imhann, MJ Bonder, AV Vila, J Fu, Z Mujagic, L Vork, EF Tigchelaar, ...
Gut 65 (5), 740-748, 2016
4342016
The effect of host genetics on the gut microbiome
MJ Bonder, A Kurilshikov, EF Tigchelaar, Z Mujagic, F Imhann, AV Vila, ...
Nature genetics 48 (11), 1407-1412, 2016
3252016
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
S Sanna, NR van Zuydam, A Mahajan, A Kurilshikov, AV Vila, U Vősa, ...
Nature genetics 51 (4), 600-605, 2019
1462019
Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics
EF Tigchelaar, A Zhernakova, JAM Dekens, G Hermes, A Baranska, ...
BMJ open 5 (8), 2015
1142015
Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to …
Z Mujagic, S Ludidi, D Keszthelyi, MAM Hesselink, JW Kruimel, ...
Alimentary pharmacology & therapeutics 40 (3), 288-297, 2014
692014
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
AV Vila, F Imhann, V Collij, SA Jankipersadsing, T Gurry, Z Mujagic, ...
Science translational medicine 10 (472), 2018
652018
Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study
L Vork, Z Weerts, Z Mujagic, JW Kruimel, MAM Hesselink, JWM Muris, ...
Neurogastroenterology & Motility 30 (2), e13189, 2018
352018
Volatile organic compounds in exhaled air as novel marker for disease activity in Crohn's disease: a metabolomic approach
AGL Bodelier, A Smolinska, A Baranska, JW Dallinga, Z Mujagic, ...
Inflammatory bowel diseases 21 (8), 1776-1785, 2015
352015
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
S Ludidi, Z Mujagic, D Jonkers, D Keszthelyi, M Hesselink, J Kruimel, ...
Neurogastroenterology & Motility 26 (8), 1104-1111, 2014
352014
The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial
Z Mujagic, P De Vos, MV Boekschoten, C Govers, HJHM Pieters, ...
Scientific reports 7 (1), 1-11, 2017
342017
Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach
A Baranska, Z Mujagic, A Smolinska, JW Dallinga, D Jonkers, ...
Alimentary pharmacology & therapeutics 44 (1), 45-56, 2016
312016
Alterations in serotonin metabolism in the irritable bowel syndrome
AY Thijssen, Z Mujagic, D Jonkers, S Ludidi, D Keszthelyi, MA Hesselink, ...
Alimentary pharmacology & therapeutics 43 (2), 272-282, 2016
302016
Systematic review: instruments to assess abdominal pain in irritable bowel syndrome
Z Mujagic, D Keszthelyi, Q Aziz, W Reinisch, EG Quetglas, ...
Alimentary pharmacology & therapeutics 42 (9), 1064-1081, 2015
302015
A novel biomarker panel for irritable bowel syndrome and the application in the general population
Z Mujagic, EF Tigchelaar, A Zhernakova, T Ludwig, J Ramiro-Garcia, ...
Scientific reports 6, 26420, 2016
282016
The Experience Sampling Method‐a new digital tool for momentary symptom assessment in IBS: an exploratory study
Z Mujagic, C Leue, L Vork, R Lousberg, D Jonkers, D Keszthelyi, ...
Neurogastroenterology & Motility 27 (9), 1295-1302, 2015
282015
Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease
EG Quetglas, Z Mujagic, S Wigge, D Keszthelyi, S Wachten, A Masclee, ...
World journal of gastroenterology 21 (44), 12519, 2015
272015
Management of neck metastases of unknown primary origin united in two European centers
J Straetmans, J Vent, M Lacko, EJ Speel, C Huebbers, R Semrau, ...
European Archives of Oto-Rhino-Laryngology 272 (1), 195-205, 2015
272015
Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome
Z Mujagic, D Jonkers, S Ludidi, D Keszthelyi, MA Hesselink, Z Weerts, ...
Neurogastroenterology & Motility 29 (12), e13137, 2017
192017
Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries
Z Mujagic, DMAE Jonkers, APS Hungin, NJ de Wit, KA Wensaas, M Palka, ...
European journal of gastroenterology & hepatology 29 (6), 651-656, 2017
162017
The system can't perform the operation now. Try again later.
Articles 1–20